Focusing on the tumor microenvironment, single-cell analysis in PDAC identified TGFβ-driven LRRC15+ CAFs that surround tumor islets, are absent in normal tissue, and whose high signature correlates with poor anti-PD-L1 response, highlighting a translational target to improve immunotherapy outcomes [153]. The gene discussed is LRRC15; the disease is neoplasm.